< Back to previous page
Project
Single domain antibodies that neutralize SARS-CoV-2
The aim of this project is to isolate single domain antibodies that are directed against the receptor-binding domain that is part of the spike protein of SARS-CoV-2. Those single-domain antibodies, separately and combined, will be evaluated for their capacity to neutralize SARS-CoV-2.
Date:15 Apr 2020 → 14 Jan 2021
Keywords:Coronavirus, virus neutralization, antibody
Disciplines:Infectious diseases, Virology, Medical molecular engineering of nucleic acids and proteins